LAI Antipsychotics Show Superior Outcomes for Older Schizophrenia Patients
Medical Xpress1 min read86 words
Long‑acting injectable (LAI) antipsychotics have been shown to deliver superior treatment outcomes compared with oral antipsychotic medications, according to a study conducted by a research team at the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong (HKUMed). The investigation focused on patients aged 65 and older who are diagnosed with schizophrenia.
The findings indicate that older schizophrenia patients receiving LAI antipsychotics experience better therapeutic results than those treated with oral formulations, underscoring the potential benefits of injectable options for this population.
Read the original at Medical Xpress
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.